Clinical trial
Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
NCT00003968 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003968 |
|---|---|
| Title | Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer |
| Official title | Phase II Study of Bryostatin-1 in Metastatic Renal Cell Carcinoma(Summary Last Modified 8/1999) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug |
| Interventions | bryostatin 1 |
| Enrollment | 35 |
| Start date | Jun 1, 1999 |
| Primary completion | Dec 1, 2003 |
| First posted | May 3, 2004 |
| Last update posted | Feb 8, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: